The conservative battle against ObamaCare won't end with Halbig

Halbig may die in the courts. But ObamaCare's difficulties will live on.

Obama
(Image credit: (Alex Wong/Getty Images))

No matter how you feel about Halbig vs. Sebelius — the recent decision that said it was illegal for the government to funnel subsidies to the 36 states that declined to build health care exchanges — the odds that this legal challenge to ObamaCare will ultimately prevail in the courts are not that high. But the law's supporters should brace themselves for even fiercer future battles: Their folly was to pass a complicated and flawed law with zero Republican support, and now they have to contend with full-bore Republican opposition as they try to make it work.

Halbig's odds of being upheld are low, not because its legal argument is "stupid" or "criminal," as its opponents claim, but because of courtroom politics. Halbig was issued by a three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit, but the full court tilts heavily liberal, and it is likely to reverse the decision.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Shikha Dalmia

Shikha Dalmia is a visiting fellow at the Mercatus Center at George Mason University studying the rise of populist authoritarianism.  She is a Bloomberg View contributor and a columnist at the Washington Examiner, and she also writes regularly for The New York Times, USA Today, The Wall Street Journal, and numerous other publications. She considers herself to be a progressive libertarian and an agnostic with Buddhist longings and a Sufi soul.